Management of Eptifibatide Induced Severe Thrombocytopenia After Percutaneous Coronary InterventionBoldt, Christopher a; Pham, Caitlynn a,d; Eisenmenger, Elizabeth b; Oyenubi, Olamide c; Bushan, Sita ba Baylor College of Medicine, Department of Medicineb Baylor College of Medicine, Department of Medicine – Hematology and Oncologyc Baylor College of Medicine, Department of Medicine – Cardiologyd Correspondence: Caitlynn Pham, ctpham@bcm.eduKey Clinical Message: The purpose of this study is to provide readers with a case in which eptifibatide, an anti-platelet commonly used after percutaneous coronary intervention, caused severe drug-induced thrombocytopenia. We highlight the treatment options and outcomes for this patient to further provide guidance for clinicians who find themselves in similar situations.